These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36645496)

  • 21. 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival.
    Sun MY; Linsenbardt AJ; Emnett CM; Eisenman LN; Izumi Y; Zorumski CF; Mennerick S
    Neuroscientist; 2016 Apr; 22(2):132-44. PubMed ID: 25628343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitfalls of NMDA Receptor Modulation by Neuroactive Steroids. The Effect of Positive and Negative Modulation of NMDA Receptors in an Animal Model of Schizophrenia.
    Holubova K; Chvojkova M; Hrcka Krausova B; Vyklicky V; Kudova E; Chodounska H; Vyklicky L; Vales K
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A neuroactive steroid with a therapeutically interesting constellation of actions at GABA
    Ziolkowski L; Mordukhovich I; Chen DM; Chisari M; Shu HJ; Lambert PM; Qian M; Zorumski CF; Covey DF; Mennerick S
    Neuropharmacology; 2021 Feb; 183():108358. PubMed ID: 33115614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.
    Xu Y; Song R; Perszyk RE; Chen W; Kim S; Park KL; Allen JP; Nocilla KA; Zhang J; XiangWei W; Tankovic A; McDaniels ED; Sheikh R; Mizu RK; Karamchandani MM; Hu C; Kusumoto H; Pecha J; Cappuccio G; Gaitanis J; Sullivan J; Shashi V; Petrovski S; Jauss RT; Lee HK; Bozarth X; Lynch DR; Helbig I; Pierson TM; Boerkoel CF; Myers SJ; Lemke JR; Benke TA; Yuan H; Traynelis SF
    Cell Mol Life Sci; 2024 Mar; 81(1):153. PubMed ID: 38538865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.
    Emnett CM; Eisenman LN; Mohan J; Taylor AA; Doherty JJ; Paul SM; Zorumski CF; Mennerick S
    Br J Pharmacol; 2015 Mar; 172(5):1333-47. PubMed ID: 25377730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.
    Burnell ES; Irvine M; Fang G; Sapkota K; Jane DE; Monaghan DT
    J Med Chem; 2019 Jan; 62(1):3-23. PubMed ID: 29446949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of NMDA receptor regulation.
    Mony L; Paoletti P
    Curr Opin Neurobiol; 2023 Dec; 83():102815. PubMed ID: 37988826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different oxysterols have opposing actions at N-methyl-D-aspartate receptors.
    Linsenbardt AJ; Taylor A; Emnett CM; Doherty JJ; Krishnan K; Covey DF; Paul SM; Zorumski CF; Mennerick S
    Neuropharmacology; 2014 Oct; 85():232-42. PubMed ID: 24878244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites.
    Goldsmith PJ
    Curr Top Med Chem; 2019; 19(24):2239-2253. PubMed ID: 31660834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel opening.
    Xie L; McDaniel MJ; Perszyk RE; Kim S; Cappuccio G; Shapiro KA; Muñoz-Cabello B; Sanchez-Lara PA; Grand K; Zhang J; Nocilla KA; Sheikh R; Armengol L; Romano R; Pierson TM; Yuan H; Myers SJ; Traynelis SF
    Cell Mol Life Sci; 2023 Mar; 80(4):110. PubMed ID: 37000222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroactive steroids as endogenous modulators of anxiety.
    Eser D; Baghai TC; Schüle C; Nothdurfter C; Rupprecht R
    Curr Pharm Des; 2008; 14(33):3525-33. PubMed ID: 19075729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Class of Potent N-Methyl-D-Aspartate Receptor Inhibitors: Sulfated Neuroactive Steroids with Lipophilic D-Ring Modifications.
    Kudova E; Chodounska H; Slavikova B; Budesinsky M; Nekardova M; Vyklicky V; Krausova B; Svehla P; Vyklicky L
    J Med Chem; 2015 Aug; 58(15):5950-66. PubMed ID: 26171651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface Expression, Function, and Pharmacology of Disease-Associated Mutations in the Membrane Domain of the Human GluN2B Subunit.
    Vyklicky V; Krausova B; Cerny J; Ladislav M; Smejkalova T; Kysilov B; Korinek M; Danacikova S; Horak M; Chodounska H; Kudova E; Vyklicky L
    Front Mol Neurosci; 2018; 11():110. PubMed ID: 29681796
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    XiangWei W; Jiang Y; Yuan H
    Curr Opin Physiol; 2018 Apr; 2():27-35. PubMed ID: 29756080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of missense variants in the N-methyl-d-aspartate receptor GRIN gene family as gain- or loss-of-function.
    Myers SJ; Yuan H; Perszyk RE; Zhang J; Kim S; Nocilla KA; Allen JP; Bain JM; Lemke JR; Lal D; Benke TA; Traynelis SF
    Hum Mol Genet; 2023 Sep; 32(19):2857-2871. PubMed ID: 37369021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism.
    Kostakis E; Smith C; Jang MK; Martin SC; Richards KG; Russek SJ; Gibbs TT; Farb DH
    Mol Pharmacol; 2013 Aug; 84(2):261-74. PubMed ID: 23716622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation.
    Sun MY; Taylor A; Zorumski CF; Mennerick S
    PLoS One; 2017; 12(3):e0174416. PubMed ID: 28346482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.